
Science 37
Total Raised
$106.5MInvestors Count
14Deal Terms
3Investments
1Funding, Valuation & Revenue
7 Fundings
Science 37 has raised $106.5M over 7 rounds.
Science 37's latest funding round was a Take Private for on March 12, 2024.
Science 37's latest post-money valuation is from March 2024.
Sign up for a free demo to see Science 37's valuations in March 2024 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
3/12/2024 | Take Private | 4 | ||||
10/7/2021 | Reverse Merger | |||||
8/20/2020 | Series D - II | |||||
3/1/2019 | Series D | |||||
4/25/2017 | Series C |
Date | 3/12/2024 | 10/7/2021 | 8/20/2020 | 3/1/2019 | 4/25/2017 |
|---|---|---|---|---|---|
Round | Take Private | Reverse Merger | Series D - II | Series D | Series C |
Amount | |||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 4 |
Science 37 Deal Terms
3 Deal Terms
Science 37's deal structure is available for 3 funding rounds, including their Take Private from March 12, 2024.
Round | Take Private | Series B | Series A |
|---|---|---|---|
Funding Date | |||
Pre-Money Valuation | |||
Post-Money Valuation | |||
Amount Raised | |||
Shares Authorized | |||
Issuance Price | |||
Dividend Rate | |||
Liquidation Preferences | |||
Liquidation Price | |||
Participation | |||
Conversion Price | |||
Anti Dilution | |||
General Voting | |||
Board Voting | |||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Take Private | |||||||||||||||
Series B | |||||||||||||||
Series A |
Science 37 Investors
14 Investors
Science 37 has 14 investors. eMed invested in Science 37's Take Private funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
3/12/2024 | 3/12/2024 | 1 Take Private | Corporation | Massachusetts | ||
10/7/2021 | 10/7/2021 | 1 Reverse Merger | SPAC | New York | ||
10/20/2015 | 8/20/2020 | 5 Series A, Series B (2016), Series C (2017), Series D (2019), Series D - II (2020) | Venture Capital | Switzerland | ||
Venture Capital | New York | |||||
Hedge Fund | California |
First funding | 3/12/2024 | 10/7/2021 | 10/20/2015 | ||
|---|---|---|---|---|---|
Last Funding | 3/12/2024 | 10/7/2021 | 8/20/2020 | ||
Investor | |||||
Rounds | 1 Take Private | 1 Reverse Merger | 5 Series A, Series B (2016), Series C (2017), Series D (2019), Series D - II (2020) | ||
Board Seats | |||||
Type | Corporation | SPAC | Venture Capital | Venture Capital | Hedge Fund |
Location | Massachusetts | New York | Switzerland | New York | California |
Science 37 Investments
1 Investments
Science 37 has made 1 investments. Their latest investment was in Lindus Health as part of their Series A on August 16, 2023.
Science 37 Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
8/16/2023 | Series A | Lindus Health | $18M | Yes | Creandum, Curebase, Florence Healthcare, Koneksa Health, Peter Thiel, Seedcamp, and Undisclosed Investors | 1 |
Date | 8/16/2023 |
|---|---|
Round | Series A |
Company | Lindus Health |
Amount | $18M |
New? | Yes |
Co-Investors | Creandum, Curebase, Florence Healthcare, Koneksa Health, Peter Thiel, Seedcamp, and Undisclosed Investors |
Sources | 1 |
Compare Science 37 to Competitors

Medable specializes in the development of decentralized clinical trial software and electronic Clinical Outcome Assessment (eCOA) solutions within the healthcare technology sector. The company's platform provides tools for remote monitoring, data collection, and trial management, utilizing artificial intelligence (AI) to improve processes in clinical research. Medable serves the pharmaceutical and biotechnology industries, including mid to large pharma, emerging biotech firms, and contract research organizations (CROs). Medable was formerly known as Dermatrap. It was founded in 2012 and is based in Palo Alto, California.

Castor operates within the healthcare sector and provides a clinical trial platform designed for the design, deployment, patient engagement, data collection, and analysis of clinical trials. The platform is adaptable and can meet the requirements of different stakeholders in the clinical research process. It primarily serves the healthcare sector. The company was founded in 2012 and is based in Amsterdam, Netherlands.

Curebase is a company that provides an eClinical platform in the clinical research sector, offering tools such as electronic patient-reported outcomes (ePRO), electronic clinical outcome assessments (eCOA), electronic consent (eConsent), and electronic data capture (EDC) systems. The platform is designed for study launches, data collection, and participant engagement. It was founded in 2017 and is based in San Francisco, California.

ObvioHealth is a digital health organization focused on improving clinical trials through technology. The company offers a platform for conducting decentralized and hybrid clinical trials, providing services such as study design, participant recruitment, electronic consent and enrollment, data capture and monitoring, and analytics and reporting. ObvioHealth serves the healthcare sectors, including CROs, medical devices, pharmaceuticals, biotechnology, and consumer health industries. It was founded in 2017 and is based in New York, New York.

Reify Health provides digital solutions and infrastructure within the healthcare and pharmaceutical sectors to support the clinical trials ecosystem. The company offers cloud-based software aimed at trial enrollment processes and supplies the infrastructure required for clinical research. Reify Health serves biopharma companies, research clinics, and healthcare and community organizations. Reify Health was formerly known as ZeroSum Health. It was founded in 2012 and is based in Boston, Massachusetts.

Evidation is involved in measuring health in everyday life within the digital health sector. The company provides a platform for individuals to track health activities, participate in research, and manage their data privacy. Evidation serves the life sciences, government, and non-profit organizations. It was founded in 2012 and is based in San Mateo, California.
Loading...

